144 related articles for article (PubMed ID: 30480806)
1. c-Met inhibition is required for the celecoxib-attenuated stemness property of human colorectal cancer cells.
Lin YM; Lu CC; Hsiang YP; Pi SC; Chen CI; Cheng KC; Pan HL; Chien PH; Chen YJ
J Cell Physiol; 2019 Jul; 234(7):10336-10344. PubMed ID: 30480806
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.
Valverde A; Peñarando J; Cañas A; López-Sánchez LM; Conde F; Hernández V; Peralbo E; López-Pedrera C; de la Haba-Rodríguez J; Aranda E; Rodríguez-Ariza A
PLoS One; 2015; 10(6):e0131363. PubMed ID: 26107817
[TBL] [Abstract][Full Text] [Related]
6. COX-2 inhibition and colorectal cancer.
Koehne CH; Dubois RN
Semin Oncol; 2004 Apr; 31(2 Suppl 7):12-21. PubMed ID: 15252926
[TBL] [Abstract][Full Text] [Related]
7. Whole-Body PET Imaging in Humans Shows That
Kim MJ; Anaya FJ; Manly LS; Lee JH; Hong J; Shrestha S; Telu S; Henry K; Santamaria JAM; Liow JS; Zanotti-Fregonara P; Shetty HU; Zoghbi SS; Pike VW; Innis RB
J Nucl Med; 2023 Jan; 64(1):159-164. PubMed ID: 35798558
[TBL] [Abstract][Full Text] [Related]
8. COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages.
Voloshyna I; Kasselman LJ; Carsons SE; Littlefield MJ; Gomolin IH; De Leon J; Reiss AB
J Investig Med; 2017 Mar; 65(3):694-704. PubMed ID: 27940550
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer.
Tuynman JB; Vermeulen L; Boon EM; Kemper K; Zwinderman AH; Peppelenbosch MP; Richel DJ
Cancer Res; 2008 Feb; 68(4):1213-20. PubMed ID: 18281498
[TBL] [Abstract][Full Text] [Related]
11. HSP90 inhibitor enhances anti-proliferative and apoptotic effects of celecoxib on HT-29 colorectal cancer cells via increasing BAX/BCL-2 ratio.
Mohammadi A; Yaghoobi MM; GholamhoseynianNajar A; Kalantari-Khandani B; Sharifi H; Saravani M
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):62-67. PubMed ID: 27894402
[TBL] [Abstract][Full Text] [Related]
12. Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells.
Qorri B; Harless W; Szewczuk MR
Drug Des Devel Ther; 2020; 14():4149-4167. PubMed ID: 33116404
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib inhibits osteoblast differentiation independent of cyclooxygenase activity.
Matsuyama A; Higashi S; Tanizaki S; Morotomi T; Washio A; Ohsumi T; Kitamura C; Takeuchi H
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):75-83. PubMed ID: 28815657
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
15. Gut-Restricted Selective Cyclooxygenase-2 (COX-2) Inhibitors for Chemoprevention of Colorectal Cancer.
Zhang Z; Ghosh A; Connolly PJ; King P; Wilde T; Wang J; Dong Y; Li X; Liao D; Chen H; Tian G; Suarez J; Bonnette WG; Pande V; Diloreto KA; Shi Y; Patel S; Pietrak B; Szewczuk L; Sensenhauser C; Dallas S; Edwards JP; Bachman KE; Evans DC
J Med Chem; 2021 Aug; 64(15):11570-11596. PubMed ID: 34279934
[TBL] [Abstract][Full Text] [Related]
16. Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.
Lee SJ; Park MK; Shin DS; Chun MH
Drug Des Devel Ther; 2017; 11():2727-2736. PubMed ID: 29066864
[TBL] [Abstract][Full Text] [Related]
17. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
[TBL] [Abstract][Full Text] [Related]
19. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review.
Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR
Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981
[TBL] [Abstract][Full Text] [Related]
20. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
Wallace JL; McKnight W; Reuter BK; Vergnolle N
Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
